Development of novel treatment and prevention for chronic eosinophilic rhinosinusitis using myeloid-derived suppressor cells.
Project/Area Number |
16K15721
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Otorhinolaryngology
|
Research Institution | Okayama University |
Principal Investigator |
|
Project Period (FY) |
2016-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
Fiscal Year 2017: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2016: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | 好酸球性副鼻腔炎 / 骨髄由来免疫抑制細胞 / プロスタグランジンE2合成酵素 / 鼻茸 / PGE2 / PGE2合成酵素 / IL-10 |
Outline of Final Research Achievements |
As compared with uncinate process mucosa, nasal polyp (NP) showed higher expression of myeloiod-derived suppressor cells (MDSC). In addition, NP from eosinophilic chronic rhinosinusitis (ECRS) showed higher expression of MDSC as compared with NP from non-ECRS. Moreover,lineage (-) HLA-DR (-) CD33 (+) MDSC showed higher expression of prostaglandin E2 synthetase-1 (PGES-1) mRNA as compared with lineage (-) cells as well as lingeage (-) HLA-DR (+) cells. These results suggest that MDSC are involved in pathogenesis of ECRS via expression of PGES-1.
|
Report
(3 results)
Research Products
(7 results)
-
-
-
-
-
[Journal Article] Regulatory effect of TLR3 signaling on staphylococcal enterotoxin-induced IL-5, IL-13, IL-17A and IFN-γ production in chronic rhinosinusitis with nasal polyps2016
Author(s)
Okano M, Fujiwara T, Kariya S, Higaki T, Makihara S, Haruna T, Noyama Y, Koyama T, Omichi R, Orita Y, Miki K, Kanai K, Nishizaki K.
-
Journal Title
Allergology International
Volume: 65
Issue: 1
Pages: 96-102
DOI
NAID
ISSN
1323-8930, 1440-1592
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
-